Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9851715rdf:typepubmed:Citationlld:pubmed
pubmed-article:9851715lifeskim:mentionsumls-concept:C0001675lld:lifeskim
pubmed-article:9851715lifeskim:mentionsumls-concept:C0020205lld:lifeskim
pubmed-article:9851715lifeskim:mentionsumls-concept:C1882598lld:lifeskim
pubmed-article:9851715lifeskim:mentionsumls-concept:C0439855lld:lifeskim
pubmed-article:9851715lifeskim:mentionsumls-concept:C1704711lld:lifeskim
pubmed-article:9851715lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:9851715lifeskim:mentionsumls-concept:C1706818lld:lifeskim
pubmed-article:9851715lifeskim:mentionsumls-concept:C0205391lld:lifeskim
pubmed-article:9851715pubmed:issue1lld:pubmed
pubmed-article:9851715pubmed:dateCreated1998-12-28lld:pubmed
pubmed-article:9851715pubmed:abstractTextThis paper extends our earlier work on the analysis of neutral N-glycans from adult rat brain to glycans carrying NeuAc residues as their sole charged groups. These structures comprised at least 40% of the total (acidic and neutral) N-glycan pool. Compounds were identified by a combination of endoglycosidase and exoglycosidase digestions, anion-exchange chromatography, normal and reverse-phase high-performance liquid chromatography, matrix-assisted laser desorption/ionisation-mass spectrometry and combined gas chromatography/mass spectrometry. Mono-, di- and trisialylated components, together with components substituted with four (or more) NeuAc residues, showed abundances of approximately 12, 10, 7 and 7%, respectively, relative to the total N-glycan pool. In addition, neuraminidase digestion resulted in the neutralisation of a fraction of highly charged species, possibly indicating the presence of N-glycans substituted with short chains of polysialic acid. Sialylated bi-, tri- [mainly the (2,4)-branched isomer], tetraantennary complex, polylactosamine and hybrid structures were detected. Typically, for 'brain-type' N-glycosylation, these sialylated structures were variously modified by the presence of core alpha1-6-linked and outer-arm alpha1-3-linked fucose residues and by a bisecting GlcNAc. Structural groups such as sialyl Lewis(x) and NeuAc alpha2-3 substituted Galbeta1-4GlcNAc antennae were common. In contrast to the neutral glycans, however, a widespread distribution of terminal beta1-3-linked galactose residues was observed. The presence of beta1-3-linked galactose allowed for a high degree of sialylation as afforded by the presence of the NeuAc alpha2-3Galbeta1-3(NeuAc alpha2-6)GlcNAc structural group. This revealed a number of novel structures including the presence of tetraantennary N-glycans with more than one beta1-3galactose residue and (2,4)-branched triantennary oligosaccharides containing three such residues. Disialylated hybrid glycans containing beta1-3-linked galactose and 'polylactosamine' N-glycans with one to three terminal beta1-3galactose residues were additional novel features. The N-glycans modified by polysialylation lacked outer-arm fucose and bisecting GlcNAc residues but all contained one or more terminal beta1-3-linked galactose residues. These may be representative, therefore, of the polysialylated N-glycans expressed mainly on neural cell-adhesion molecules and known to be present in adult rat brain. The diversity of presentation of terminal sialylated groups in rat brain implies potential specificity for possible charge or lectin-mediated interactions. The distinguishing sets of sialylated structures described here are indicative of differences in the natural glycosylation processing pathways in different cell types within the central nervous system, a specificity that may be further magnified on the individual glycoproteins.lld:pubmed
pubmed-article:9851715pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9851715pubmed:languageenglld:pubmed
pubmed-article:9851715pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9851715pubmed:citationSubsetIMlld:pubmed
pubmed-article:9851715pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9851715pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9851715pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9851715pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9851715pubmed:statusMEDLINElld:pubmed
pubmed-article:9851715pubmed:monthNovlld:pubmed
pubmed-article:9851715pubmed:issn0014-2956lld:pubmed
pubmed-article:9851715pubmed:authorpubmed-author:DwekR ARAlld:pubmed
pubmed-article:9851715pubmed:authorpubmed-author:HarveyD JDJlld:pubmed
pubmed-article:9851715pubmed:authorpubmed-author:WingD RDRlld:pubmed
pubmed-article:9851715pubmed:authorpubmed-author:ChenY JYJlld:pubmed
pubmed-article:9851715pubmed:authorpubmed-author:ZamzeSSlld:pubmed
pubmed-article:9851715pubmed:authorpubmed-author:GuileG RGRlld:pubmed
pubmed-article:9851715pubmed:issnTypePrintlld:pubmed
pubmed-article:9851715pubmed:day15lld:pubmed
pubmed-article:9851715pubmed:volume258lld:pubmed
pubmed-article:9851715pubmed:ownerNLMlld:pubmed
pubmed-article:9851715pubmed:authorsCompleteYlld:pubmed
pubmed-article:9851715pubmed:pagination243-70lld:pubmed
pubmed-article:9851715pubmed:dateRevised2009-9-29lld:pubmed
pubmed-article:9851715pubmed:meshHeadingpubmed-meshheading:9851715-...lld:pubmed
pubmed-article:9851715pubmed:meshHeadingpubmed-meshheading:9851715-...lld:pubmed
pubmed-article:9851715pubmed:meshHeadingpubmed-meshheading:9851715-...lld:pubmed
pubmed-article:9851715pubmed:meshHeadingpubmed-meshheading:9851715-...lld:pubmed
pubmed-article:9851715pubmed:meshHeadingpubmed-meshheading:9851715-...lld:pubmed
pubmed-article:9851715pubmed:meshHeadingpubmed-meshheading:9851715-...lld:pubmed
pubmed-article:9851715pubmed:meshHeadingpubmed-meshheading:9851715-...lld:pubmed
pubmed-article:9851715pubmed:meshHeadingpubmed-meshheading:9851715-...lld:pubmed
pubmed-article:9851715pubmed:meshHeadingpubmed-meshheading:9851715-...lld:pubmed
pubmed-article:9851715pubmed:meshHeadingpubmed-meshheading:9851715-...lld:pubmed
pubmed-article:9851715pubmed:meshHeadingpubmed-meshheading:9851715-...lld:pubmed
pubmed-article:9851715pubmed:meshHeadingpubmed-meshheading:9851715-...lld:pubmed
pubmed-article:9851715pubmed:meshHeadingpubmed-meshheading:9851715-...lld:pubmed
pubmed-article:9851715pubmed:year1998lld:pubmed
pubmed-article:9851715pubmed:articleTitleSialylated N-glycans in adult rat brain tissue--a widespread distribution of disialylated antennae in complex and hybrid structures.lld:pubmed
pubmed-article:9851715pubmed:affiliationOxford Glycobiology Institute, Department of Biochemistry, University of Oxford, UK.lld:pubmed
pubmed-article:9851715pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9851715pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9851715lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9851715lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9851715lld:pubmed